Concepedia

Roland A. L. Gendron

RA

9

Publications

151

Citations

9

H-Index

2000

Active since

Affiliations

Theravance Biopharma (United States)(Current)

University of Victoria

Roland A. L. Gendron is an author at Theravance Biopharma (United States) specializing in inorganic chemistry, chemistry, and engineering.

Top concepts

Publications per year

2000–2018

9

Publications

9

Dibenzylzirconium Complexes of Chelating Aminodiolates. Synthesis, Structural Studies, Thermal Stability, and Insertion Chemistry

Pengcheng Shao, Roland A. L. Gendron, David Van Den Berg et al. · Organometallics · 2000 · 34 citations

, , +11

Discovery, oral pharmacokinetics and in vivo efficacy of velusetrag, a highly selective 5-HT4 receptor agonist that has achieved proof-of-concept in patients with chronic idiopathic constipation

Daniel D. Long, Scott R. Armstrong, David T. Beattie et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 22 citations · Full text

, , +8

A Multivalent Approach to the Design and Discovery of Orally Efficacious 5-HT<sub>4</sub>Receptor Agonists

R. Murray McKinnell, Scott R. Armstrong, David T. Beattie et al. · Journal of Medicinal Chemistry · 2009 · 21 citations · Full text

Synthesis, solid state structure, and solution behaviour of the lighter lanthanide bis(trimethylsilyl)amido chlorides, [Ln{N(SiMe<sub>3</sub>)<sub>2</sub>}<sub>2</sub>(THF)(µ-Cl)]<sub>2</sub> (Ln = Ce, Nd)

David J. Berg, Roland A. L. Gendron · Canadian Journal of Chemistry · 2000 · 21 citations

, , +12

Discovery of TD-0212, an Orally Active Dual Pharmacology AT<sub>1</sub> Antagonist and Neprilysin Inhibitor (ARNI)

R. Murray McKinnell, Paul R. Fatheree, Seok Ki Choi et al. · ACS Medicinal Chemistry Letters · 2018 · 12 citations · Full text

Rows per page

1–5 of 9